Thromb Haemost 2009; 102(06): 1080-1092
DOI: 10.1160/TH09-07-0499
Theme Issue Article
Schattauer GmbH

Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli

Martina Bielaszewska*
1   Institute of Hygiene, University of Münster, Münster, Germany
,
Andreas Bauwens*
1   Institute of Hygiene, University of Münster, Münster, Germany
,
Lilo Greune
2   Institute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
,
Björn Kemper
3   Center for Biomedical Optics and Photonics, University of Münster, Münster, Germany
,
Ulrich Dobrindt
4   Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany
,
Joyce M. Geelen
5   Department of Pediatric Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
,
Kwang S. Kim
6   Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
M. Alexander Schmidt
2   Institute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
,
Helge Karch
1   Institute of Hygiene, University of Münster, Münster, Germany
› Author Affiliations
Financial support: This study was supported by the Deutsche Forschungsgemeinschaft (DFG) program “Infections of the endothelium” SPP 1130 (grant no. KA 717/4–2), by a grant from the DFG-funded International Graduate School “Molecular interactions of pathogens with biotic and abiotic surfaces” (GRK1409), by the DFG Collaborative Research Centers SFB293 (Project B5) and SFB479 (Project A1), by the ERA-NET PathoGenoMics (grants no. PTJ-BIO/0313937A and PTJ-BIO/0313937C), by the German Competence Network PathoGenoMik (PTJ-BIO/03U213BVBIIIPG3), and by the German Federal Ministry for Education and Research (BMBF) research program “Biophotonics”.
Further Information

Publication History

Received: 10 July 2009

Accepted after major revision: 06 October 2009

Publication Date:
28 November 2017 (online)

Zoom Image

Summary

Enterohaemorrhagic Escherichia coli (EHEC) cause haemolytic uraemic syndrome (HUS),a thrombotic microangiopathy resulting from endothelial injury in the renal glomeruli and other organs. EHEC virulence factors that damage the microvascular endothelium play therefore major roles in the pathogenesis of HUS.We identified an EHEC strain that vacuolates and kills primary human glomerular microvascular endothelial cells (GMVECs) and a human brain microvascular endothelial cell (HBMEC) line. Because the vacuolating effect closely resembles those elicited on other cells by the vacuolating cytotoxin of Helicobacter pylori (VacA), we designated the factor responsible for this effect EHEC vacuolating cytotoxin (EHEC-Vac). EHEC-Vac (a secreted non-serine protease protein) binds to HBMECs rapidly and irreversibly, vacuolates within 30 min after exposure and the effect is maximally apparent at 48 h. Despite the vacuolisation, HBMECs survive for several days before they undergo necrosis. Electron and immunofluorescence microscopy demonstrate that the vacuoles induced by EHEC-Vac originate from lysosomes.Accordingly, they stain with neutral red indicating an acidic microenvironment. Similar to VacA, the EHEC-Vac-mediated vacuolisation is both prevented and reverted by the vacuolar proton pump inhibitor bafilomycin A1, suggesting a similar mechanism of vacuole formation by these toxins. Despite the similarity of phenotypes elicited by EHEC-Vac and VacA, genomic DNA from the EHEC-Vac-producing strain failed to hybridise to a vacA probe, as well as to probes derived from presently known E. coli vacuolating toxins.Through its microvascular endothelium-injuring potential combined with the ability to induce interleukin 6 release from these cells EHEC-Vac might contribute to the pathogenesis of HUS.

* Both authors contributed equally to this study.